1).Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67.
2).Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-40.
3).Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999- 2000. Circulation. 2004;110(6):738-43.
4).宮田 哲郎. 末梢閉塞性動脈疾患の治療ガイドライン (2015 年改訂版).
5).Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. Jama. 2006;295(2):180- 9.
6).Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter- Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-654.
7).Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):e71-e126.
8).Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816.
9).Alahdab F, Wang AT, Elraiyah TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3 Suppl):42s-53s.
10).Conte MS, Pomposelli FB, Clair DG, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61(3 Suppl):2s-41s.
11).de L, II, Hoeks SE, van Gestel YR, et al. The prognostic value of impaired walking distance on long-term outcome in patients with known or suspected peripheral arterial disease. Eur J Vasc Endovasc Surg. 2009;38(4):482-7.
12).McDermott MM, Liu K, Ferrucci L, et al. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol. 2011;57(8):962-70.
13).McDermott MM, Liu K, Tian L, et al. Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. J Am Coll Cardiol. 2012;59(13):1159-67.
14).Singh N, Liu K, Tian L, et al. Leg strength predicts mortality in men but not in women with peripheral arterial disease. J Vasc Surg. 2010;52(3):624-31.
15).Leeper NJ, Myers J, Zhou M, et al. Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg. 2013;57(3):728-33.
16).Garg PK, Tian L, Criqui MH, et al. Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation. 2006;114(3):242-8.
17).Conte MS, Bradbury AW, Kolh P, er al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6s):3S-125S.e40.
18).Scherer SA, Bainbridge JS, Hiatt WR, et al. Gait characteristics of patients with claudication. Arch Phys Med Rehabil. 1998;79(5):529-31.
19).Gardner AW, Forrester L, Smith GV. Altered gait profile in subjects with peripheral arterial disease. Vasc Med. 2001;6(1):31-4.
20).Salbach NM, O'Brien KK, Brooks D, et al. Reference values for standardized tests of walking speed and distance: a systematic review. Gait Posture. 2015;41(2):341-60.
21).Lelas JL, Merriman GJ, Riley PO, et al. Predicting peak kinematic and kinetic parameters from gait speed. Gait Posture. 2003;17(2):106-12.
22).A.Winter D. Biomechanics and Motor Control of Human Movement 4th edition. Hoboken, New Jersey: John Wiley & Sons, Inc; 2009.
23).Bowden MG, Balasubramanian CK, Neptune RR, et al. Anterior-posterior ground reaction forces as a measure of paretic leg contribution in hemiparetic walking. Stroke. 2006;37(3):872-6.
24).Hsiao H, Knarr BA, Higginson JS, et al. The relative contribution of ankle moment and trailing limb angle to propulsive force during gait. Hum Mov Sci. 2015;39:212-21.
25).Tyrell CM, Roos MA, Rudolph KS, et al. Influence of systematic increases in treadmill walking speed on gait kinematics after stroke. Phys Ther. 2011;91(3):392-403.
26).Lewek MD, Sawicki GS. Trailing limb angle is a surrogate for propulsive limb forces during walking post-stroke. Clin Biomech (Bristol, Avon). 2019;67:115-8.
27).Crowther RG, Spinks WL, Leicht AS, et al. Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease. J Vasc Surg. 2007;45(6):1172-8.
28).Chen SJ, Pipinos I, Johanning J, et al. Bilateral claudication results in alterations in the gait biomechanics at the hip and ankle joints. J Biomech. 2008;41(11):2506-14.
29).Celis R, Pipinos, II, Scott-Pandorf MM, et al. Peripheral arterial disease affects kinematics during walking. J Vasc Surg. 2009;49(1):127-32.
30).Koutakis P, Johanning JM, Haynatzki GR, et al. Abnormal joint powers before and after the onset of claudication symptoms. J Vasc Surg. 2010;52(2):340-7.
31).Koutakis P, Pipinos, II, Myers SA, et al. Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication. J Vasc Surg. 2010;51(1):80- 8.
32).Wurdeman SR, Koutakis P, Myers SA, et al. Patients with peripheral arterial disease exhibit reduced joint powers compared to velocity-matched controls. Gait Posture. 2012;36(3):506-9.
33).Kakihana T, Ito O, Sekiguchi Y, et al. Hip flexor muscle dysfunction during walking at self-selected and fast speed in patients with aortoiliac peripheral arterial disease. J Vasc Surg. 2017;66(2):523-32.
34).牧田 茂, 安 隆則. 心血管疾患におけるリハビリテーションに関するガイドライン (2021年改訂版)
35).Fakhry F, Fokkenrood HJ, Spronk S, et al. Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Database Syst Rev. 2018;3(3):Cd010512.
36).Al-Jundi W, Madbak K, Beard JD, et al. Systematic review of home-based exercise programmes for individuals with intermittent claudication. Eur J Vasc Endovasc Surg. 2013;46(6):690-706.
37).Vemulapalli S, Dolor RJ, Hasselblad V, et al. Supervised vs unsupervised exercise for intermittent claudication: A systematic review and meta-analysis. Am Heart J. 2015;169(6):924-37.e3.
38).Indes JE, Pfaff MJ, Farrokhyar F, et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther. 2013;20(4):443-55.
39).Dake MD, Ansel GM, Jaff MR, et al. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation. 2016;133(15):1472-83; discussion 83.
40).Klinkert P, Post PN, Breslau PJ, et al. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004;27(4):357-62.
41).Gerhard-Herman M, Gardin JM, Jaff M, et al. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11(3):183-200.
42).Sekiguchi Y, Muraki T, Izumi S, et al. The contribution of quasi-joint stiffness of the ankle joint to gait in patients with hemiparesis. Clin Biomech (Bristol, Avon). 2012;27(5):495- 9.
43).Eng JJ, Winter DA. Kinetic analysis of the lower limbs during walking: what information can be gained from a three-dimensional model? J Biomech. 1995;28(6):753-8.
44).Gardner AW, Montgomery PS, Wang M, et al. Association between calf muscle oxygen saturation with ambulatory function and quality of life in symptomatic patients with peripheral artery disease. J Vasc Surg. 2020;72(2):632-42.
45).Figoni SF, Kunkel CF, Scremin AM, et al. Effects of exercise training on calf tissue oxygenation in men with intermittent claudication. Pm r. 2009;1(10):932-40.
46).Nicolaï SP, Kruidenier LM, Rouwet EV, et al. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg. 2009;50(1):89-94.
47).Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452-8.
48).Beckitt TA, Day J, Morgan M, et al. Calf muscle oxygen saturation and the effects of supervised exercise training for intermittent claudication. J Vasc Surg. 2012;56(2):470-5.
49).Regensteiner JG, Wolfel EE, Brass EP, et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation. 1993;87(2):413-21.
50).Pipinos, II, Judge AR, Selsby JT, et al. The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovascular Surg. 2007;41(6):481-9.
51).Pipinos, II, Judge AR, Selsby JT, et al. The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vasc Endovascular Surg. 2008;42(2):101-12.
52).McDermott MM, Ferrucci L, Guralnik J, et al. Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease. Circulation. 2009;120(12):1048-55.
53).Haga M, Hoshina K, Koyama H, et al. Bicycle exercise training improves ambulation in patients with peripheral artery disease. J Vasc Surg. 2020;71(3):979-87.
54).Guilleron C, Abraham P, Beaune B, et al. Location of ischemia and ischemic pain intensity affect spatiotemporal parameters and leg muscles activity during walking in patients with intermittent claudication. Sci Rep. 2021;11(1):6809.
55).Rexroth W, Hageloch W, Isgro F, et al. Influence of peripheral arterial occlusive disease on muscular metabolism. Part 1: Changes in lactate, ammonia, and hypoxanthine concentration in femoral blood. Klin Wochenschr. 1989;67(11):576-82.
56).Girn HR, Orsi NM, Homer-Vanniasinkam S. An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease. Vasc Med. 2007;12(4):299- 309.
57).Leardini-Tristao M, Charles AL, Lejay A, et al. Beneficial Effect of Exercise on Cognitive Function during Peripheral Arterial Disease: Potential Involvement of Myokines and Microglial Anti-Inflammatory Phenotype Enhancement. J Clin Med. 2019;8(5).
58).Abraham P, Ouedraogo N, Tew GA, et al. Aging reduces the accuracy of self-reported walking limitation in patients with vascular-type claudication. J Vasc Surg. 2012;56(4):1025- 31.
59).McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116(9):1540-50.
60).Crowther RG, Spinks WL, Leicht AS, et al. Intralimb coordination variability in peripheral arterial disease. Clin Biomech (Bristol, Avon). 2008;23(3):357-64.
61).Doya K. What are the computations of the cerebellum, the basal ganglia and the cerebral cortex? Neural Netw. 1999;12(7-8):961-74.
62).Huisinga JM, Pipinos, II, Johanning JM, et al. The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients. J Neuroeng Rehabil. 2010;7:25.
63).Yentes JM, Huisinga JM, Myers SA, et al. Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain. J Appl Biomech. 2012;28(2):184-91.
64).Farah BQ, Santos MF, Cucato GG, et al. Effect of frailty on physical activity levels and walking capacity in patients with peripheral artery disease: A cross-sectional study. J Vasc Nurs. 2021;39(3):84-8.
65).King S, Vanicek N, Mockford KA, et al. The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication. Clin Biomech (Bristol, Avon). 2012;27(8):845-51.
66).Schieber MN, Pipinos, II, Johanning JM, et al. Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease. J Vasc Surg. 2020;71(2):575-83.
67).Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(1):130-9.
68).Djerf H, Millinger J, Falkenberg M, et al. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial. Circ Cardiovasc Interv. 2020;13(1):e008450.
69).Fakhry F, Spronk S, van der Laan L, et al. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial. Jama. 2015;314(18):1936-44.
70).Persch LN, Ugrinowitsch C, Pereira G, et al. Strength training improves fall-related gait kinematics in the elderly: a randomized controlled trial. Clin Biomech (Bristol, Avon). 2009;24(10):819-25.
71).Nicholson VP, McKean MR, Burkett BJ. Low-load high-repetition resistance training improves strength and gait speed in middle-aged and older adults. J Sci Med Sport. 2015;18(5):596-600.
72).Papa EV, Dong X, Hassan M. Resistance training for activity limitations in older adults with skeletal muscle function deficits: a systematic review. Clin Interv Aging. 2017;12:955- 61.
73).Blears EE, Elias JK, Tapking C, et al. Supervised Resistance Training on Functional Capacity, Muscle Strength and Vascular Function in Peripheral Artery Disease: An Updated Systematic Review and Meta-Analysis. J Clin Med. 2021;10(10).
74).Machado I, Sousa N, Paredes H, et al. Combined Aerobic and Resistance Exercise in Walking Performance of Patients With Intermittent Claudication: Systematic Review. Front Physiol. 2019;10:1538.
75).Mazari FA, Khan JA, Carradice D, et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg. 2012;99(1):39-48.
76).Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. Jama. 2011;305(1):50-8.
77).Hardy SE, Perera S, Roumani YF, et al. Improvement in usual gait speed predicts better survival in older adults. J Am Geriatr Soc. 2007;55(11):1727-34.
78).Sakamoto S, Yokoyama N, Tamori Y, et al. Patients with peripheral artery disease who complete 12-week supervised exercise training program show reduced cardiovascular mortality and morbidity. Circ J. 2009;73(1):167-73.
79).McGibbon CA. Toward a better understanding of gait changes with age and disablement: neuromuscular adaptation. Exerc Sport Sci Rev. 2003;31(2):102-8.
80).Beijersbergen CM, Granacher U, Vandervoort AA, et al. The biomechanical mechanism of how strength and power training improves walking speed in old adults remains unknown. Ageing Res Rev. 2013;12(2):618-27.
81).Cofré LE, Lythgo N, Morgan D, et al. Aging modifies joint power and work when gait speeds are matched. Gait Posture. 2011;33(3):484-9.
82).天笠 志保, 荒神 裕之, 井上 茂. 医療・健康分野におけるスマートフォンおよびウェアラブルデバイスを用いた身体活動の評価：現状と今後の展望. Japanese Society of Public Health. 2021;68(9):585-96.
83).Jonkers I, Delp S, Patten C. Capacity to increase walking speed is limited by impaired hip and ankle power generation in lower functioning persons post-stroke. Gait Posture. 2009;29(1):129-37.
84).Ko SU, Stenholm S, Chia CW, et al. Gait pattern alterations in older adults associated with type 2 diabetes in the absence of peripheral neuropathy--results from the Baltimore Longitudinal Study of Aging. Gait Posture. 2011;34(4):548-52.
論文の公開元へ
